The above chart presents the market trend analysis for indigo pharmaceuticals ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 24 transactions, with a transaction quantity of 8475 and a transaction weight of 0.
indigo pharmaceuticals ltd. is sudan Buyer,
and primarily engages in the import and export business of products such as bat,lp,tablet.
According to the 52wmb.com global trade database, as of 2025-04-11, the company has completed 2122 international trades,
with its main trading regions covering india etc.
The core products include HS30049099,HS30021290,HS90183100 etc,
often transported via mombasa,port juba, port kemba etc,
and its main trading partners are alps life science pvt ltd.,zeal pharma,hindustan medicine traders.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on indigo pharmaceuticals ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.